Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jake Dunning

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
BMJ (Clinical Research Ed.)|May 3, 2014
Potential adverse effects of negative publicity surrounding antivirals for influenzaJake Dunning
The Lancet. Infectious Diseases|December 15, 2022
An opportunity seized: rapid clinical research provides insights into monkeypox virus dynamics and durations of infectiousnessJake Dunning, Chinwe Ochu
The Journal of Antimicrobial Chemotherapy|August 1, 2009
Novel strategies to treat antiretroviral-naive HIV-infected patientsJake Dunning, Mark Nelson
Lancet (London, England)|December 24, 2014
Ebola: the battle plan must include specific treatmentsJake Dunning, William Fischer
The Lancet. Infectious Diseases|May 3, 2017
Insights from clinical research completed during the west Africa Ebola virus disease epidemicAmanda Rojek, Peter Horby, Jake Dunning
The Lancet. Infectious Diseases|August 5, 2022
Monkeypox: how will we know if the treatments work?Amanda Rojek, Jake Dunning, Piero Olliaro
Journal of Medical Microbiology|March 12, 2025
Cases of high-consequence infectious diseases identified in the UK, 1962-2023Barry Atkinson, Mike Beadsworth, Jake Dunning
Lancet (London, England)|November 8, 2020
Early triple antiviral therapy for COVID-19Nelson Lee, Michael Ison, Jake Dunning
Journal of Medical Microbiology|June 16, 2026
Corrigendum: Cases of high consequence infectious diseases identified in the UK, 1962-2023Barry Atkinson, Mike Beadsworth, Jake Dunning
The British Journal of Ophthalmology|October 10, 2022
Monkeypox as an emerging infectious disease: the ophthalmic implicationsAlice L Milligan, Su-Yin Koay, Jake Dunning
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
BMJ (Clinical Research Ed.)|May 3, 2014
Potential adverse effects of negative publicity surrounding antivirals for influenzaJake Dunning
The Lancet. Infectious Diseases|December 15, 2022
An opportunity seized: rapid clinical research provides insights into monkeypox virus dynamics and durations of infectiousnessJake Dunning, Chinwe Ochu
The Journal of Antimicrobial Chemotherapy|August 1, 2009
Novel strategies to treat antiretroviral-naive HIV-infected patientsJake Dunning, Mark Nelson
Lancet (London, England)|December 24, 2014
Ebola: the battle plan must include specific treatmentsJake Dunning, William Fischer
The Lancet. Infectious Diseases|May 3, 2017
Insights from clinical research completed during the west Africa Ebola virus disease epidemicAmanda Rojek, Peter Horby, Jake Dunning
The Lancet. Infectious Diseases|August 5, 2022
Monkeypox: how will we know if the treatments work?Amanda Rojek, Jake Dunning, Piero Olliaro
Journal of Medical Microbiology|March 12, 2025
Cases of high-consequence infectious diseases identified in the UK, 1962-2023Barry Atkinson, Mike Beadsworth, Jake Dunning
Lancet (London, England)|November 8, 2020
Early triple antiviral therapy for COVID-19Nelson Lee, Michael Ison, Jake Dunning
Journal of Medical Microbiology|June 16, 2026
Corrigendum: Cases of high consequence infectious diseases identified in the UK, 1962-2023Barry Atkinson, Mike Beadsworth, Jake Dunning
The British Journal of Ophthalmology|October 10, 2022
Monkeypox as an emerging infectious disease: the ophthalmic implicationsAlice L Milligan, Su-Yin Koay, Jake Dunning
Pageof 13